A detailed history of Cornerstone Planning Group LLC transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 1 shares of ONTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 33 96.97%
Holding current value
$0
Previous $12,000 58.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
N/A
-32 Reduced 96.97%
1 $5,000
Q1 2024

May 07, 2024

BUY
$0.67 - $1.01 $22 - $33
33 New
33 $21,000
Q4 2022

Feb 14, 2023

BUY
$0.63 - $0.97 $20 - $32
33 New
33 $29,000

Others Institutions Holding ONTX

About Onconova Therapeutics, Inc.


  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.